Cargando…
Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review
Background: Borneol is a terpene and bicyclic organic compound that can be extracted from plants or chemically synthesized. As an important component of proprietary Chinese medicine for the treatment of stroke, its neuroprotective effects have been confirmed in many experiments. Unfortunately, there...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129537/ https://www.ncbi.nlm.nih.gov/pubmed/34017247 http://dx.doi.org/10.3389/fphar.2021.606682 |
_version_ | 1783694312844820480 |
---|---|
author | Li, Yong Ren, Mihong Wang, Jiajun Ma, Rong Chen, Hai Xie, Qian Li, Hongyan Li, Jinxiu Wang, Jian |
author_facet | Li, Yong Ren, Mihong Wang, Jiajun Ma, Rong Chen, Hai Xie, Qian Li, Hongyan Li, Jinxiu Wang, Jian |
author_sort | Li, Yong |
collection | PubMed |
description | Background: Borneol is a terpene and bicyclic organic compound that can be extracted from plants or chemically synthesized. As an important component of proprietary Chinese medicine for the treatment of stroke, its neuroprotective effects have been confirmed in many experiments. Unfortunately, there is no systematic review of these studies. This study aimed to systematically examine the neuroprotective effects of borneol in the cascade reaction of experimental ischemic stroke at different periods. Methods: Articles on animal experiments and cell-based research on the actions of borneol against ischemic stroke in the past 20°years were collected from Google Scholar, Web of Science, PubMed, ScienceDirect, China National Knowledge Infrastructure (CNKI), and other biomedical databases. Meta-analysis was performed on key indicators in vivo experiments. After sorting the articles, we focused on the neuroprotective effects and mechanism of action of borneol at different stages of cerebral ischemia. Results: Borneol is effective in the prevention and treatment of nerve injury in ischemic stroke. Its mechanisms of action include improvement of cerebral blood flow, inhibition of neuronal excitotoxicity, blocking of Ca(2+) overload, and resistance to reactive oxygen species injury in the acute ischemic stage. In the subacute ischemic stage, borneol may antagonize blood-brain barrier injury, intervene in inflammatory reactions, and prevent neuron excessive death. In the late stage, borneol promotes neurogenesis and angiogenesis in the treatment of ischemic stroke. Conclusion: Borneol prevents neuronal injury after cerebral ischemia via multiple action mechanisms, and it can mobilize endogenous nutritional factors to hasten repair and regeneration of brain tissue. Because the neuroprotective effects of borneol are mediated by various therapeutic factors, deficiency caused by a single-target drug is avoided. Besides, borneol promotes other drugs to pass through the blood-brain barrier to exert synergistic therapeutic effects. |
format | Online Article Text |
id | pubmed-8129537 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81295372021-05-19 Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review Li, Yong Ren, Mihong Wang, Jiajun Ma, Rong Chen, Hai Xie, Qian Li, Hongyan Li, Jinxiu Wang, Jian Front Pharmacol Pharmacology Background: Borneol is a terpene and bicyclic organic compound that can be extracted from plants or chemically synthesized. As an important component of proprietary Chinese medicine for the treatment of stroke, its neuroprotective effects have been confirmed in many experiments. Unfortunately, there is no systematic review of these studies. This study aimed to systematically examine the neuroprotective effects of borneol in the cascade reaction of experimental ischemic stroke at different periods. Methods: Articles on animal experiments and cell-based research on the actions of borneol against ischemic stroke in the past 20°years were collected from Google Scholar, Web of Science, PubMed, ScienceDirect, China National Knowledge Infrastructure (CNKI), and other biomedical databases. Meta-analysis was performed on key indicators in vivo experiments. After sorting the articles, we focused on the neuroprotective effects and mechanism of action of borneol at different stages of cerebral ischemia. Results: Borneol is effective in the prevention and treatment of nerve injury in ischemic stroke. Its mechanisms of action include improvement of cerebral blood flow, inhibition of neuronal excitotoxicity, blocking of Ca(2+) overload, and resistance to reactive oxygen species injury in the acute ischemic stage. In the subacute ischemic stage, borneol may antagonize blood-brain barrier injury, intervene in inflammatory reactions, and prevent neuron excessive death. In the late stage, borneol promotes neurogenesis and angiogenesis in the treatment of ischemic stroke. Conclusion: Borneol prevents neuronal injury after cerebral ischemia via multiple action mechanisms, and it can mobilize endogenous nutritional factors to hasten repair and regeneration of brain tissue. Because the neuroprotective effects of borneol are mediated by various therapeutic factors, deficiency caused by a single-target drug is avoided. Besides, borneol promotes other drugs to pass through the blood-brain barrier to exert synergistic therapeutic effects. Frontiers Media S.A. 2021-05-04 /pmc/articles/PMC8129537/ /pubmed/34017247 http://dx.doi.org/10.3389/fphar.2021.606682 Text en Copyright © 2021 Li, Ren, Wang, Ma, Chen, Xie, Li, Li and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Yong Ren, Mihong Wang, Jiajun Ma, Rong Chen, Hai Xie, Qian Li, Hongyan Li, Jinxiu Wang, Jian Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review |
title | Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review |
title_full | Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review |
title_fullStr | Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review |
title_full_unstemmed | Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review |
title_short | Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review |
title_sort | progress in borneol intervention for ischemic stroke: a systematic review |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129537/ https://www.ncbi.nlm.nih.gov/pubmed/34017247 http://dx.doi.org/10.3389/fphar.2021.606682 |
work_keys_str_mv | AT liyong progressinborneolinterventionforischemicstrokeasystematicreview AT renmihong progressinborneolinterventionforischemicstrokeasystematicreview AT wangjiajun progressinborneolinterventionforischemicstrokeasystematicreview AT marong progressinborneolinterventionforischemicstrokeasystematicreview AT chenhai progressinborneolinterventionforischemicstrokeasystematicreview AT xieqian progressinborneolinterventionforischemicstrokeasystematicreview AT lihongyan progressinborneolinterventionforischemicstrokeasystematicreview AT lijinxiu progressinborneolinterventionforischemicstrokeasystematicreview AT wangjian progressinborneolinterventionforischemicstrokeasystematicreview |